Vimta Labs Limited announced that the recommendations of the nomination and remuneration committee approved the following, subject to approval of shareholders at the ensuing Annual General Meeting of the company: Noting of cessation of term of Shri V V Prasad as Executive Director Administration with effect from July 14, 2019. Noting of appointment of Shri Satya Sreenivas Neerukonda as additional director on May 11, 2019 with effect from 14 July, 2019. Noting of cessation of term of Shri Totapalli Sundar Raman Ajai, Independent Director with effect from 16 May, 2019. Noting of cessation of term of Shri Rao Purnachandra Potharlanka, Independent Director with effect from 16th May, 2019. Appointment of Additional Directors Shri G Purnachandra Rao, Shri Popuri Adheyya Chowdary and Shri Sanjay Dave with effect from May 11, 2019.
Vimta Labs Limited is engaged in the business of contract research and testing organization. The Company is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include Drug discovery, development, and drug life cycle management support services; Preclinical research and testing services for medical device companies; Contract research and testing for agrochemical and specialty chemical companies; and Food testing and analytical development services to support manufacturers, processors, farmers, and retailers; Clinical diagnostics services to patients, clinicians, and hospitals, and environmental regulatory services such as impact assessments and post project monitoring, to various industries, such as power and infrastructure.
VIMTA LABS LIMITED 
